Orthofix Medical Stock Alpha and Beta Analysis
| OFIX Stock | USD 18.61 0.29 1.58% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Orthofix Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Orthofix Medical over a specified time horizon. Remember, high Orthofix Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Orthofix Medical's market risk premium analysis include:
Beta 0.7 | Alpha (0.06) | Risk 1.41 | Sharpe Ratio 0.0271 | Expected Return 0.0382 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Orthofix |
Orthofix Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Orthofix Medical market risk premium is the additional return an investor will receive from holding Orthofix Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orthofix Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Orthofix Medical's performance over market.| α | -0.06 | β | 0.70 |
Orthofix Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Orthofix Medical's Buy-and-hold return. Our buy-and-hold chart shows how Orthofix Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Orthofix Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Orthofix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orthofix Medical shares will generate the highest return on investment. By understating and applying Orthofix Medical stock market price indicators, traders can identify Orthofix Medical position entry and exit signals to maximize returns.
Orthofix Medical Return and Market Media
The median price of Orthofix Medical for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 18.29 with a coefficient of variation of 3.75. The daily time series for the period is distributed with a sample standard deviation of 0.69, arithmetic mean of 18.25, and mean deviation of 0.55. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 2955 shares by Kevin Kenny of Orthofix Medical at 12.67 subject to Rule 16b-3 | 12/06/2024 |
2 | Disposition of tradable shares by Geoffrey Gillespie of Orthofix Medical at 17.84 subject to Rule 16b-3 | 12/17/2024 |
3 | Orthofix medical CAO sells 463 in common stock - Investing.com | 12/20/2024 |
4 | Bone Growth Products Market Focused Insights 2024-2029 Global Players Medtronic, Johnson Johnson, Stryker and Zimmer Biomet Lead through Acquisitions, Collabora... | 12/31/2024 |
5 | Disposition of 238 shares by Geoffrey Gillespie of Orthofix Medical at 17.1352 subject to Rule 16b-3 | 01/07/2025 |
6 | Disposition of 227 shares by Geoffrey Gillespie of Orthofix Medical at 17.1419 subject to Rule 16b-3 | 01/13/2025 |
7 | Disposition of 4655 shares by Julie Andrews of Orthofix Medical at 17.89 subject to Rule 16b-3 | 01/16/2025 |
8 | Orthofix medical CFO Julie Andrews sells 83,277 in stock - Investing.com | 01/21/2025 |
9 | Canaccord Genuity Group Begins Coverage on Orthofix Medical | 01/24/2025 |
10 | Disposition of 767 shares by Geoffrey Gillespie of Orthofix Medical at 17.79 subject to Rule 16b-3 | 02/03/2025 |
11 | Disposition of 187 shares by Geoffrey Gillespie of Orthofix Medical at 18.08 subject to Rule 16b-3 | 02/04/2025 |
12 | PEEK Surgical Screws Market Research 2025-2030 Revenues to Grow by Over 220 Million, Led by Orthofix Medical, Medtronic, and Invibio | 02/07/2025 |
About Orthofix Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Orthofix or other stocks. Alpha measures the amount that position in Orthofix Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 65.64 | 62.62 | 72.01 | 100.6 | PTB Ratio | 1.22 | 0.83 | 0.95 | 0.9 |
Orthofix Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Orthofix Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Orthofix Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Orthofix Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Orthofix Medical. Please utilize our Beneish M Score to check the likelihood of Orthofix Medical's management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Orthofix Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.